Treatment of acute pandysautonomia with intravenous immunoglobulin.
AUTOR(ES)
Mericle, R A
RESUMO
Acute pandysautonomia has been suggested to be an uncommon variant of Guillain-Barre syndrome. Acute pandysautonomia does not seem to have been treated with intravenous immunoglobulin or other therapies proved efficacious in Guillain-Barre syndrome. A patient is reported with severe acute pandysautonomia who responded dramatically to intravenous immunoglobulin. The findings are consistent with a dysimmune pathogenesis for this syndrome and suggest a possible treatment for future cases.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=486878Documentos Relacionados
- Successful treatment of stiff man syndrome with intravenous immunoglobulin.
- Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin.
- Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin.
- Eczema after intravenous infusion of immunoglobulin.
- Atypical C-ANCA following high dose intravenous immunoglobulin.